Skip to main content

Purine and Pyrimidine Metabolism in Man VI

Part A: Clinical and Molecular Biology

  • Book
  • © 1989

Overview

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 253A)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (89 chapters)

  1. Human Diseases and Enzyme Abnormalities

Keywords

About this book

These two volumes contain articles presented at the Vlth International Symposium on Human Purine and Pyrimidine Metabolism held in Hakone, Japan ,July 17 trough 21, 1988. The first meeting of this series of symposia convened in Tel Aviv, Israel, and since then meetings have taken place every three years in various parts of the world. The second meeting was held in Baden, Austria, the third in Madrid, Spain, the fourth in Maastricht, the Netherlands, and fifth in San Diego, California. The Vlth meeting in Hakone marked the first such symposium held in Asia. On occasion of publishing these books, I would like to describe how research in this field has evolved in Japan. Early in the 1950s, I was engaged in clinical practice treating various rheumatic diseases as an orthopedicist, and found that a substantial percentage of our patients had symptoms apparently compatible with gout. During the 1960s, the number of these gouty patients increased, and in the 1970s, research on the pathogenesis of gout was performed on the basis of approximately 2,000 cases of this disease, together with precise epidemiological studies concerning gouty and hyperuricemic individuals. Data derived from the two kinds of study had greatly changed the notion that gout was a rare disease among Japanese. My clinical studies have been succeeded by research at the molecular level on various purine metabolic abnormalities, including not only gout but also other diseases with various symptoms of wide clinical spectra.

Editors and Affiliations

  • Mikanagi Gotanda Hospital, Tokyo, Japan

    Kiyonobu Mikanagi

  • Tokyo Women’s Medical College, Tokyo, Japan

    Kusuki Nishioka

  • University of Michigan Medical Center, Ann Arbor, USA

    William N. Kelley

Bibliographic Information

  • Book Title: Purine and Pyrimidine Metabolism in Man VI

  • Book Subtitle: Part A: Clinical and Molecular Biology

  • Editors: Kiyonobu Mikanagi, Kusuki Nishioka, William N. Kelley

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4684-5673-8

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1989

  • Softcover ISBN: 978-1-4684-5675-2Published: 17 April 2013

  • eBook ISBN: 978-1-4684-5673-8Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XIII, 560

  • Topics: Biochemistry, general

Publish with us